PureTech Health plc (LON:PRTC - Get Free Report) shares were down 15.2% during trading on Tuesday . The stock traded as low as GBX 117.20 ($1.53) and last traded at GBX 117.20 ($1.53). Approximately 42,764,352 shares traded hands during mid-day trading, an increase of 2,645% from the average daily volume of 1,557,904 shares. The stock had previously closed at GBX 138.20 ($1.81).
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reaffirmed a "buy" rating and issued a GBX 455 ($5.96) price objective on shares of PureTech Health in a report on Monday, December 16th.
View Our Latest Report on PureTech Health
PureTech Health Trading Up 14.6 %
The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The firm's 50 day moving average is GBX 135.24 and its two-hundred day moving average is GBX 148.08. The stock has a market cap of £354.45 million, a price-to-earnings ratio of -4.84 and a beta of 1.02.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Recommended Stories
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
